That ended in 2023
K., Thomsen, M., Wortwein, G
It is FDA-approved for chronic weight management in adults with obesity or adults with overweight who also have at least one weight-related health condition
IV Sessions A typical IV session at the clinic involves settling into a comfortable chair while our IV nurse places the IV line
Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial
In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit